Research site

Alyatec

France 1 Place De L Hopital, 67000 STRASBOURG, Alsace, France

Conjunctivitis allergic · Rhinitis allergic
Children and adolescents

About Specializations

Alyatec in STRASBOURG, Alsace, France specialises in clinical trials of conditions such as Conjunctivitis allergic, Rhinitis allergic, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases – Birch Pollen Allergy Research

At Alyatec the focus is on immune system diseases, specifically birch pollen‑induced allergic rhinoconjunctivitis. The trials aim to evaluate new sublingual immunotherapy treatments to reduce symptoms and rescue medication use in children and adolescents.

Clinical efficacy of a birch pollen SLIT tablet in pediatric patients
Comparison of active treatment versus placebo in seasonal allergy management
Safety assessment of long‑term sublingual therapy for birch pollen allergy
Impact of treatment on quality of life and rescue medication use

These studies support the development of innovative allergy therapies and provide data to improve care for patients suffering from seasonal allergic rhinitis.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

1 Place De L Hopital67000 STRASBOURG, AlsaceFrance

Open in maps ↗

Recruiting now: no trials
Conditions studied: 2

More sites in STRASBOURG, Alsace France

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

2 clinical trials

Conjunctivitis allergic+1

Not yet recruiting

Investigational

Efficacy of Tree SLIT-tablet and Betula pendula pollen extract in adolescents (12‑17) with allergic rhinitis/rhinoconjunctivitis caused by birch pollen

Investigational

France

Participants:0–17 years
Substances:Betula Pendula Pollen Extract
Sponsor:Alk-Abello A/S

Contact Research Centre

Conjunctivitis allergic

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug

France

Participants:0–17 years
Substances:Betula Pollen Extract
Sponsor:Stallergenes

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites